SCHEMBL17599367

SCHEMBL17599367

Cc1ccc2sc(S(=O)(=O)Nc3ccc(-c4cccc(C(=O)O)c4)c4ccccc34)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PFKFB4 Q16877 2/20 0.47
KMT2A Q03164 3/20 0.43
MCL1 Q07820 3/20 0.42
KIT P10721 1/20 0.40
BRD4 O60885 1/20 0.39
FBP1 P09467 1/20 0.39
METAP2 P50579 1/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 1/20 0.39
G6PD P11413 1/20 0.39
MAP1LC3B Q9GZQ8 1/20 0.39
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
PFKFB3 Q16875 1/20 0.38
ACLY P53396 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599312 0.81 KEAP1 (0.61) KMT2AMCL1METAP2MEN1GAA
SCHEMBL788574 0.80 PFKFB4 (0.60) PFKFB4KMT2AKITMEN1PFKFB3
SCHEMBL17599407 0.79 ACLY (0.58) PFKFB4KMT2AMCL1MEN1KDM4E
SCHEMBL17613332 0.79 SERPINE1 (0.36) KMT2AKDM4ENPSR1
SCHEMBL17599337 0.79 PTK2B (0.50) KMT2AMEN1GAAG6PDMAP1LC3B
SCHEMBL17599343 0.78 KEAP1 (0.46) PFKFB4KMT2AMCL1KITBRD4
SCHEMBL17599376 0.77 FABP4 (0.56) KMT2AMEN1GAAG6PDMAP1LC3B
SCHEMBL17599390 0.77 KEAP1 (0.56) PFKFB4KMT2AMCL1BRD4KDM4E
SCHEMBL17599362 0.76 KMT2A (0.46) KMT2AMCL1MEN1GAAG6PD
SCHEMBL17599401 0.76 PFKFB4 (0.69) PFKFB4NPSR1PFKFB3KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 EP disclosed